Recent Finacing
Recent Raise
Revalesio develops charge-stabilized nanostructure (CSN) therapeutics, including oxygen-rich saline RNS60 that modulates membrane PI3K–Akt signaling to reduce inflammation and cell damage for neurological and respiratory diseases.
Focus Areas
Total Raised
Funding round